Dr. Agarwal's Eye Hospital Beheer

Beheer criteriumcontroles 1/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Adil Agarwal

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	5.4yrs
Eigendom CEO	n/a
Management gemiddelde ambtstermijn	1.5yrs
Gemiddelde ambtstermijn bestuur	5.4yrs

Recente managementupdates

Recent updates

CEO

Adil Agarwal (41 yo)

5.4yrs

Tenure

₹300,000

Compensatie

Dr. Adil Agarwal serves as Chief Executive Officer at Dr. Agarwal's Eye Hospital Limited and serves as its Whole -Time Director from 2024. Dr. Agarwal serves as Chief Executive Officer and Director at Dr A...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Amar Agarwal	Founder	30.6yrs	₹23.62m	geen gegevens
Athiya Agarwal	Founder & Whole Time Director	no data	₹9.20m	geen gegevens
Yashwanth Venkat	Interim Chief Financial Officer	less than a year	₹5.07m	geen gegevens
Meenakshi Jayaraman	Company Secretary & Compliance Officer	2.9yrs	₹1.60m	geen gegevens
Adil Agarwal	CEO & Whole -Time Director	no data	₹300.00k	geen gegevens
Suhasini K	Head of Human Resource	no data	geen gegevens	geen gegevens
Aman Joshi	Head of Digital Marketing	less than a year	geen gegevens	geen gegevens
Terence Leo Seqi	General Manager of Projects	no data	geen gegevens	geen gegevens

1.5yrs

Gemiddelde duur

47yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 526783 wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 1.5 jaar), wat duidt op een nieuw team.

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Amar Agarwal	Founder	30.6yrs	₹23.62m	geen gegevens
Athiya Agarwal	Founder & Whole Time Director	30.5yrs	₹9.20m	geen gegevens
Adil Agarwal	CEO & Whole -Time Director	5.4yrs	₹300.00k	geen gegevens
Venkatraman Balakrishnan	Independent Director	2.4yrs	₹100.00k	geen gegevens
Latha Ramanathan	Independent Director	less than a year	geen gegevens	geen gegevens
Shiv Agrawal	Independent Director	no data	geen gegevens	geen gegevens

5.4yrs

Gemiddelde duur

60yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 526783 wordt beschouwd als ervaren (gemiddelde ambtstermijn 5.4 jaar).

Dr. Agarwal's Eye Hospital Beheer

Beheer criteriumcontroles 1/4

Belangrijke informatie

Recente managementupdates

Dr. Agarwal's Eye Hospital Limited Appoints Yashwanth Venkat as Key Managerial Personnel

Dr. Agarwal's Eye Hospital Limited Appoints Aman Joshi as Head of Digital Marketing

Less than half of directors are independent

Dr. Agarwal's Eye Hospital Limited Announces Cessation of Sanjay Anand as Independent Director

Dr. Agarwal's Eye Hospital Limited, Annual General Meeting, Aug 26, 2024

Dr. Agarwal's Eye Hospital Limited Appoints Latha Ramanathan as an Additional Director

Recent updates

Dr. Agarwal's Eye Hospital Limited Announces Interim Dividend for the Financial Year 2024-25, Payable on or Before November 25, 2024

Dr. Agarwal's Eye Hospital Limited Appoints Yashwanth Venkat as Key Managerial Personnel

Dr. Agarwal's Eye Hospital Limited to Report Q2, 2025 Results on Oct 29, 2024

Investor sentiment improves as stock rises 15%

Investor sentiment improves as stock rises 19%

Dr. Agarwal's Eye Hospital Limited Appoints Aman Joshi as Head of Digital Marketing

Less than half of directors are independent

Dr. Agarwal's Eye Hospital Limited Announces Cessation of Sanjay Anand as Independent Director

Dr. Agarwal's Eye Hospital Limited Approves Dividend for the Year Ended March 31, 2024

Dr. Agarwal's Eye Hospital Limited Approves Dividend for the Year Ended March 31, 2024

Upcoming dividend of ₹2.50 per share

Dr. Agarwal's Eye Hospital Limited, Annual General Meeting, Aug 26, 2024

New minor risk - Financial position

First quarter 2025 earnings released: EPS: ₹30.02 (vs ₹24.55 in 1Q 2024)

Dr. Agarwal's Eye Hospital Limited to Report Q1, 2025 Results on Jul 25, 2024

Dr. Agarwal's Eye Hospital Limited Appoints Latha Ramanathan as an Additional Director

Full year 2024 earnings released: EPS: ₹98.64 (vs ₹78.55 in FY 2023)

Dr. Agarwal's Eye Hospital Limited Recommends Final Dividend for the Financial Year 2023-2024

Dr. Agarwal's Eye Hospital Limited to Report Q3, 2024 Results on Jan 18, 2024

Third quarter 2024 earnings released: EPS: ₹20.09 (vs ₹10.77 in 3Q 2023)

Investor sentiment improves as stock rises 20%

Upcoming dividend of ₹2.50 per share at 0.2% yield

Second quarter 2024 earnings released: EPS: ₹26.79 (vs ₹19.30 in 2Q 2023)

Dr. Agarwal's Eye Hospital Limited Declares Interim Dividend for the Financial Year 2023-24, Payable on or Before 18 November 2023

Dr. Agarwal's Eye Hospital Limited Approves Dividend for the Year Ended March 3 1, 2023

Upcoming dividend of ₹3.00 per share at 0.1% yield

Dr. Agarwal's Eye Hospital Limited, Annual General Meeting, Sep 21, 2023

Investor sentiment improves as stock rises 22%

New minor risk - Financial position

First quarter 2024 earnings released: EPS: ₹24.55 (vs ₹19.38 in 1Q 2023)

Investor sentiment improves as stock rises 21%

Dr. Agarwal's Eye Hospital Limited to Report Q1, 2024 Results on Aug 04, 2023

Investor sentiment improves as stock rises 26%

Dr. Agarwal's Eye Hospital Limited Recommends Final Dividend for the Fiscal Year 2023

Full year 2023 earnings released: EPS: ₹78.55 (vs ₹51.29 in FY 2022)

Investor sentiment improves as stock rises 25%

Investor sentiment deteriorates as stock falls 22%

Third quarter 2023 earnings released: EPS: ₹10.77 (vs ₹17.34 in 3Q 2022)

Dr. Agarwal's Eye Hospital Limited to Report Nine Months, 2023 Results on Jan 21, 2023

Investor sentiment improved over the past week

Dr. Agarwal's Eye Hospital Limited to Report Q2, 2023 Results on Oct 28, 2022

Now 21% undervalued

Dr. Agarwal's Eye Hospital Limited Approves Final Dividend for Financial Year Ended March 31, 2022

Investor sentiment improved over the past week

Upcoming dividend of ₹3.00 per share

Dr. Agarwal's Eye Hospital Limited, Annual General Meeting, Sep 14, 2022

First quarter 2023 earnings released: EPS: ₹19.38 (vs ₹1.54 loss in 1Q 2022)

Dr. Agarwal's Eye Hospital Limited to Report Q1, 2023 Results on Aug 04, 2022

Full year 2022 earnings released: EPS: ₹51.29 (vs ₹3.06 loss in FY 2021)

Dr. Agarwal's Eye Hospital Limited Recommends Dividend for the Financial Year 2022

Less than half of directors are independent

Dr. Agarwal's Eye Hospital Limited Announces Resignation of T.R. Ramasubramanian as Independent Director

Investor sentiment improved over the past week

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment improved over the past week

Investor sentiment improved over the past week

TPG Reportedly in Advanced Talks to Acquire 40% in Dr Agarwal's Health Care

Investor sentiment improved over the past week

Company Secretary & Compliance Officer Jully Jivani has left the company

First quarter 2022 earnings released: ₹1.54 loss per share (vs ₹16.19 loss in 1Q 2021)

Full year 2021 earnings released: ₹3.06 loss per share (vs ₹29.11 profit in FY 2020)

New 90-day high: ₹302

Dr. Agarwal's Eye Hospital Limited to Report Q3, 2021 Results on Jan 25, 2021

New 90-day high: ₹275

New 90-day high: ₹274

First half earnings released

Dr. Agarwal's Eye Hospital Limited to Report Q4, 2021 Results on May 30, 2021

New 90-day high - ₹266

Dr. Agarwal's Eye Hospital Limited to Report Q1, 2021 Results on Aug 12, 2020